Bottom line
Is RPEAX a good fund? The bottom line
RPEAX is the Class A share class of Davis Opportunity Fund, an actively managed large blend mutual fund from Davis.
Annual fees run 0.94% — about $94 a year on every $10,000 invested, more expensive than 59% of large blend funds we track.
It returned +16.2% over one year, +11.4% a year over five years, +11.6% a year over ten (as of Dec 31, 2025, per its prospectus).
With $652 million in net assets and 51 holdings, its largest position is Quest Diagnostics Inc (6.6%) and the top 10 make up 44.5% of the portfolio.
This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.
What to watch
- Front-end sales load up to 4.75%
- 12b-1 marketing fee of 0.22% a year
Updated Nov 19, 2026
What RPEAX invests in
The Fund seeks long-term growth of capital.
Davis Selected Advisers, L.P. (Davis Advisors or the Adviser), the Funds investment adviser, uses the Davis Investment Discipline to invest the Funds portfolio principally in common stocks (including indirect holdings of common stock through Depositary Receipts (as defined below)). The Fund may invest in large, medium or small companies without regard to market capitalization and may invest in issuers in foreign countries, including countries with developed or emerging markets. Davis Investment Discipline. Davis Advisors manages equity funds using the Davis Investment Discipline. Davis Advisors conducts extensive research to try to identify businesses that possess characteristics that Davis Advisors believes foster the creation of long-term value, such as proven management, a durable franchise and business model, and sustainable competitive advantages. Davis Advisors aims to invest in…
From the fund's prospectus (filed Apr 29, 2026).
RPEAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RPEAX | +16.2% | +11.4% | +11.6% |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What RPEAX costs
On a $10,000 investment, RPEAX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,575 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
RPEAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Quest Diagnostics Inc DGX | 6.59% |
| 2 | Viatris Inc VTRS | 6.25% |
| 3 | Wesco International Inc WCC | 6.07% |
| 4 | Devon Energy Corp DVN | 4.13% |
| 5 | Cvs Health Corp CVS | 4.04% |
| 6 | Mgm Resorts International MGM | 4.02% |
| 7 | Solventum Corp SOLV | 3.60% |
| 8 | Capital One Financial Corp COF | 3.35% |
| 9 | Stonex Repo | 3.28% |
| 10 | US Bancorp USB | 3.14% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 44.5% of the fund. See all top 25 holdings and asset mix →